Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dorzagliatin Phase 2 Study in Type 2 Diabetes
NCT02561338Phase 2Completed
- Sponsor
- Hua Medicine
- Start
- Sep 2015
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dorzagliatin in type 2 diabetes mellitus (T2DM), sponsored by Hua Medicine. Started Sep 2015; status: completed.
02
Drugs
dorzagliatin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02561338.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02561338.